下载App
扫码立即下载
  • 下载App

    扫码立即下载

  • 在线客服

    登录后咨询在线客服
+
恭喜您!
成功领取价值超 5000港元/年的高级行情
前往体验 >>
多维分析
公司估值 资金追踪 卖空分析
03309 希玛眼科
4.010
+0.020+0.50%
显示同比
不显示
隐藏空行
(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30
Per Share IndicaTor
Operating Cash Flow Per Share
31.41% 0.1255 319.38% 0.0786 -26.58% 0.0955 -72.09% 0.0187
Cash Flow Per Share
-161.75% -0.1445 -169.89% -0.0993 230% 0.234 88.2% -0.0368
Operating Income Per Share
58.62% 0.9672 98.39% 0.4541 11.25% 0.6098 -9.06% 0.2289
Net Asset Per Share
2.58% 1.1572 5.71% 1.1317 38.44% 1.1282 32.52% 1.0705
Basic Earning Per Share
433.33% 0.019 160.41% 0.0119 -114.39% -0.0057 -160.8% -0.0197
Diluted  Earning Per Share
433.33% 0.019 160.41% 0.0119 -114.73% -0.0057 -161.76% -0.0197
Profitability
Gross Profit Ratio
16.06% 32.198% 46.08% 34.301% -16.44% 27.743% -37.43% 23.481%
Operating Profit Ratio
92.64% 2.224% 193.42% 4.973% -89.08% 1.154% -130.01% -5.323%
Net Profit Ratio
221.31% 1.459% 128.44% 2.409% -117.71% -1.202% -167.67% -8.472%
Earning Before Tax Ratio
574.84% 2.416% 159.35% 4.260% -96.12% 0.358% -143.65% -7.178%
ROE
386.75% 1.665% 152.43% 1.057% -111.85% -0.581% -150.26% -2.016%
ROA
368.36% 1.220% 151.29% 0.828% -111% -0.454% -146.48% -1.614%
Yield Quality
Operating Profit To Total Profits
-71.45% 92.067% -- 116.742% 181.62% 322.524% -- --
Tax To Total Profits
-90.91% 39.609% -- 43.443% 1546.72% 435.942% -- --
Operating Cash To Total Revenue
-17.15% 12.979% 111.39% 17.314% -34.01% 15.666% -69.31% 8.191%
Capital Structure
Debt Assets Ratio
55.22% 31.629% 32.48% 22.547% -11.68% 20.377% -13.31% 17.019%
Equity Multipler
16.72% 1.4692 7.14% 1.2946 -3.68% 1.2587 -2.89% 1.2083
Debt Equity Ratio
80.77% 46.262% 41.94% 29.111% -14.67% 25.591% -16.04% 20.510%
Current Assets To tatal Assets
1.72% 38.161% -15.8% 35.882% -27.79% 37.517% -40.69% 42.617%
Non Current Assets To Total Assets
-1.03% 61.839% 11.74% 64.118% 30.05% 62.483% 103.84% 57.383%
Current Liabilities To tatal Liabilities
43.84% 65.992% 7.29% 50.523% -8.76% 45.877% -16.23% 47.089%
Non Current Liabilities To Total Liabilities
-37.16% 34.008% -6.49% 49.477% 8.86% 54.123% 20.83% 52.911%
Solvency
Current Ratio
-54.44% 1.8283 -40.77% 3.1499 -10.39% 4.0132 -18.33% 5.3176
Quick Ratio
-54.98% 1.7464 -41.76% 2.9873 -11.22% 3.879 -19.6% 5.1295
Operating Profit To Current Liabilities
14.3% 0.0606 215.12% 0.1353 -88.7% 0.053 -129.2% -0.1175
Operrating Cash Flow To Current Liabilities
-50.84% 0.3537 160.5% 0.4711 -31.67% 0.7196 -70.14% 0.1808
Share Equity Without Minority Interest To Total Liabilities
-44.81% 2.1519 -29.55% 3.4259 17.56% 3.8988 18.78% 4.8627
Operating Cash Flow To Total Liabilities
-29.29% 0.2334 179.5% 0.238 -37.66% 0.3301 -74.98% 0.0852
Operating Profit To Total Liabilities
64.41% 0.04 223.52% 0.0684 -89.69% 0.0243 -124.46% -0.0553
Operating Capacity
Inventory Turnover(T)
-4.14% 27.9974 20.89% 13.2765 -11.54% 29.2077 -18.95% 10.9823
Current Assets Turnover(T)
39.75% 1.639 98.75% 0.8584 36.81% 1.1728 24.2% 0.4319
Fixed Assets Turnover(T)
16.97% 4.2782 40.09% 2.2024 -12.77% 3.6575 6.21% 1.5721
Total Assets Turnover(T)
21.95% 0.6207 56.34% 0.3149 -11.38% 0.509 -26.02% 0.2014
Growth Ability
Operating Revenue GR 3Y
27.53% 159.116% 98.13% 171.142% -5.28% 124.769% -33.28% 86.378%
Gross Income GR 3Y
223.02% 139.879% 9473.01% 183.591% -57.31% 43.303% -101.51% -1.959%
Operating Profit GR 3Y
30.89% -59.653% 111.75% 16.475% -3749.53% -86.321% -285.88% -140.255%
EBT GR 3Y
41.43% -56.062% 100.3% 0.457% -940.97% -95.719% -335.31% -154.806%
Net Profit GR 3Y
48.85% -61.875% 102.41% 4.509% -630.41% -120.963% -407.35% -187.463%
Net Profit Attributable To The Parent Company GR 3Y
57.9% -48.648% 107.7% 14.067% -893.86% -115.566% -385.27% -182.746%
Total Assets GR 3Y
-79.85% 120.542% -75.7% 91.038% -22.36% 598.103% -- 374.588%
Share Equity Without Minority Interest GR 3Y
-91.74% 59.676% -85.47% 61.183% -42.25% 722.196% -- 421.219%
Equity GR 3Y
-91.66% 60.398% -85.42% 61.618% -42.44% 724.042% -- 422.602%
Total Liabilities GR 3Y
215.67% 1064.071% 79.95% 409.861% 13.82% 337.080% -- 227.765%
Basic Earning Per Share GR 3Y
51.02% -54.327% -- 0.000% -10.95% -110.920% -0.08% -100.026%
Net Assets Per Share GR 3Y
-90.81% 43.682% -- 44.503% -- 475.481% -- --
Other Indicators
Currency Unit
港元港元港元港元

Q6、Q9、FY为累计季报:Q6 为中期报告;Q9 为第三季报;FY为年报。

环比数据来源于季报,环比 = (本期 - 上期)/上期 * 100%

公司概况 更多
希玛眼科医疗控股有限公司是一间提供眼科服务及销售视力辅助产品及医药产品的投资控股公司。该公司提供的眼科服务包括治疗白内障、青光眼及斜视的手术以及角膜、玻璃体视网膜疾病等眼科疾病。该公司亦销售眼镜及镜片等视力辅助产品以及医药产品。该公司的主要子公司为希玛眼科医疗集团有限公司,希玛眼科集团有限公司等。
董事长: 林顺潮
所属市场: 香港主板
上市日期: 2018/01/15
富途热股榜
港股美股沪深
交易热度搜索热度资讯热度
名称代码最新价涨跌幅

加载中...

自选
回到顶部